You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


BMS partners with Sensyne Health for rare blood disease research

Clinical AI company Sensyne Health has signed a research collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research.